Answers are grounded in this paper and cite their sources.
The review describes certain viral vectors and considers various methods for constructing recombinant viruses with special attention paid to the homologous recombination and CRISPR/Cas9 system, and also describes the capabilities of using various cloning vectors (different plasmids, BAC etc.). The review also presents a comparative analysis of the effectiveness and safety of using various viral vectors, both for creating recombinant vaccines and for obtaining oncolytic viruses, as well as medicines for gene therapy.
No takes yet. Share an insight, caveat, or question.
Prokhorova et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: